We are live on
!
Find out more
DC
Diametric Capital Portfolio holdings
AUM
$385M
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
-1.96%
1 Year Est. Return
+31.69%
3 Year Est. Return
+134.95%
5 Year Est. Return
+239.28%
10 Year Est. Return
–
AUM
$385M
AUM Growth
+$11.7M
(+3.1%)
Cap. Flow
+$39.6M
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
20.37%
Holding
618
New
251
Increased
83
Reduced
136
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Precigen
PGEN
|
+$12.1M |
| 2 |
FPS
Forgent Power Solutions
FPS
|
+$4.81M |
| 3 |
PENN Entertainment
PENN
|
+$4.5M |
| 4 |
Flutter Entertainment
FLUT
|
+$3.99M |
| 5 |
A2Z Smart Technologies
AZ
|
+$3.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harrow
HROW
|
+$7.36M |
| 2 |
Red Rock Resorts
RRR
|
+$5.36M |
| 3 |
AIFC
AI Financial Corp
AIFC
|
+$5.22M |
| 4 |
Warner Bros
WBD
|
+$3.2M |
| 5 |
MGM Resorts International
MGM
|
+$2.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.21% |
| 2 | Consumer Discretionary | 14.9% |
| 3 | Technology | 14.08% |
| 4 | Industrials | 11.68% |
| 5 | Financials | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNUC
401
Frontier Nuclear and Minerals Inc
FNUC
$47.9M
| $147K | 0.04% |
+52,452
| New | +$158K |
|
|
BBOT
402
BridgeBio Oncology
BBOT
$713M
| $146K | 0.04% |
+16,280
| New | +$175K |
|
|
CTNM
403
Contineum Therapeutics
CTNM
$551M
| $140K | 0.04% |
+10,729
| New | +$144K |
|
404
Barnes & Noble Education
BNED
$412M
| $139K | 0.04% |
+15,755
| New | +$136K |
|
405
Kyverna Therapeutics
KYTX
$450M
| $139K | 0.04% |
+16,067
| New | +$134K |
|
|
FGNX
406
FG Nexus Inc
FGNX
$36.9M
| $138K | 0.04% |
+27,716
| New | +$282K |
|
407
FuboTV Inc
FUBO
$265M
| $137K | 0.04% |
+14,475
| New | +$287K |
|
|
TGEN
408
Tecogen Inc
TGEN
$106M
| $136K | 0.04% |
53,131
-96
| -0.2% | -$353 |
|
409
Immix Biopharma
IMMX
$670M
| $132K | 0.03% |
+14,539
| New | +$107K |
|
|
GENB
410
Generate Biomedicines
GENB
$1.78B
| $131K | 0.03% |
+10,497
| New | +$128K |
|
|
CMRC
411
Commerce.com Inc Series 1
CMRC
$224M
| $127K | 0.03% |
+47,674
| New | +$148K |
|
412
Alto Ingredients
ALTO
$394M
| $122K | 0.03% |
+25,115
| New | +$79.7K |
|
413
X4 Pharmaceuticals
XFOR
$348M
| $120K | 0.03% |
+28,973
| New | +$109K |
|
414
Shattuck Labs
STTK
$670M
| $119K | 0.03% |
+18,434
| New | +$87.4K |
|
415
Invivyd
IVVD
$183M
| $114K | 0.03% |
+87,807
| New | +$161K |
|
416
Lexicon Pharmaceuticals
LXRX
$999M
| $106K | 0.03% |
+67,841
| New | +$98.6K |
|
417
DoubleVerify
DV
$1.67B
| $102K | 0.03% |
+10,720
| New | +$110K |
|
418
Ovid Therapeutics
OVID
$444M
| $96K | 0.03% |
+43,262
| New | +$77.3K |
|
419
Zura Bio
ZURA
$513M
| $93.3K | 0.02% |
+15,681
| New | +$94.7K |
|
420
Lineage Cell Therapeutics
LCTX
$277M
| $93.3K | 0.02% |
+59,029
| New | +$99.5K |
|
|
QVCGA
421
DELISTED
QVC Group Inc Series A
QVCGA
| $93.1K | 0.02% |
42,913
-746
| -2% | -$4.53K |
|
422
C4 Therapeutics
CCCC
$414M
| $91K | 0.02% |
+34,594
| New | +$81.5K |
|
423
Palisade Bio
PALI
$330M
| $90.8K | 0.02% |
+51,874
| New | +$94.3K |
|
424
Senseonics Holdings Inc
SENS
$254M
| $89.3K | 0.02% |
+13,412
| New | +$94.5K |
|
425
American Resources Corp
AREC
$189M
| $88.7K | 0.02% |
+36,659
| New | +$117K |
|
Similar funds
GCP
GA
BAMG
VI
T
GAG
SCP
BHWM
Diametric Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Diametric Capital held 618 positions worth $385M, up 3.1% from $373M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Diametric Capital deployed $39.6M of net new capital in Q1 2026, opening 251 new positions and adding to 83 existing holdings. Its largest new stake was Forgent Power Solutions: 144,593 shares worth $4.23M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Harrow, an estimated $7.36M trimmed.
- Diametric Capital's largest Q1 2026 buy was Forgent Power Solutions: 144,593 shares worth $4.23M.
- Diametric Capital added most to Precigen in Q1 2026, an estimated $12.1M increase.
- Diametric Capital's biggest Q1 2026 reduction was Harrow, cutting an estimated $7.36M.
- Diametric Capital fully exited Red Rock Resorts in Q1 2026, selling an estimated $5.36M.
- Diametric Capital's ten largest holdings make up 20% of its $385M portfolio in Q1 2026.
- Diametric Capital opened 251 new positions and closed 145 in Q1 2026.
- Diametric Capital's portfolio value rose 3.1% quarter-over-quarter to $385M.
Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.